Ophthalmic devices are those devices which are used for vision correction or in ophthalmic diagnostic procedures. Ophthalmic viscoelastic devices are essential tools in ocular surgery, especially in anterior market surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ophthalmic viscoelastic devices devices market, including market shares of different players within France. Buy the latest report here.

Smarter leaders trust GlobalData

In 2021, GlobalData’s Market Model methodology determined that the leading player in the ophthalmic viscoelastic devices market in France was Carl Zeiss followed by Bausch & Lomb, Alcon, Rayner Intraocular Lenses, Aurolab and Johnson & Johnson Vision Care.

Ophthalmic viscoelastic devices are the viscoelastic materials used to maintain space in the eye during surgery. Typically, OVDs are pre-packaged in a syringe and are applied using a small tube. Essential properties of OVDs are tied to their physicochemical and rheological properties. Different types of OVDs available in the market include higher viscosity cohesive OVD and lower viscosity dispersive OVD. This category does not include OVDs with both cohesive and dispersive viscoelastic properties. Cohesive OVD, Dispersive OVD and Viscoadaptive OVD are tracked under this category.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the ophthalmic viscoelastic devices devices market within France was expected to be over $40m in 2021.

For the latest complete market share analysis of ophthalmic viscoelastic devices device market in France, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.